“Formulation and Evaluation of Extended-Release Bilayer Tablets Containing Empagliflozin and Metformin Hydrochloride for Diabetes Mellitus Management”, Int. J. Pharm. Sci. Drug Res., vol. 16, no. 5, pp. 777–787, Sep. 2024, doi: 10.25004/IJPSDR.2024.160505.